1-6 of 6
Nathalie Jeandidier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes: The RealTrend study

Denis Raccah, MD, PHD, Véronique Sulmont, MD, Yves Reznik, MD, PHD, Bruno Guerci, MD, PHD, Eric Renard, MD, PHD, Hélène Hanaire, MD, PHD, Nathalie Jeandidier, MD, PHD, Marc Nicolino, MD, PHD
Journal: Diabetes Care
Diabetes Care 2009;32(12):2245–2250
https://doi.org/10.2337/dc09-0750
Published: 18 September 2009
View article titled, Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes: <subtitle>The RealTrend study</subtitle>
Open the PDF for Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes: <subtitle>The RealTrend study</subtitle> in another window
Journal Articles

Reversible Focal Hepatic Steatosis in Type 1 Diabetic Patients Treated With Intraperitoneal Insulin Implantable Pump Therapy

Laurent Meyer, MD, Jeremy Jeantroux, MD, Jean Pierre Riveline, MD, François Moreau, MD, Sophie Boivin, MD, Thomas Moser, MD, Michel Pinget, MD, Nathalie Jeandidier, MD, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(6):e49
https://doi.org/10.2337/dc07-2393
Published: 01 June 2008
View article titled, Reversible Focal Hepatic Steatosis in Type 1 Diabetic Patients Treated With Intraperitoneal Insulin Implantable Pump Therapy
Open the PDF for Reversible Focal Hepatic Steatosis in Type 1 Diabetic Patients Treated With Intraperitoneal Insulin Implantable Pump Therapy in another window
Journal Articles

Comparison of Antigenicity of Hoechst 21PH Insulin Using Either Implantable Intraperitoneal Pump or Subcutaneous External Pump Infusion in Type 1 Diabetic Patients

Nathalie Jeandidier, MD, PHD, Sylvie Boullu, MD, Marie-Sophie Busch-Brafin, Gerard Chabrier, MD, Rémy Sapin, Françoise Gasser, Michel Pinget, MD, PHD
Journal: Diabetes Care
Diabetes Care 2002;25(1):84–88
https://doi.org/10.2337/diacare.25.1.84
Published: 01 January 2002
View article titled, Comparison of Antigenicity of Hoechst 21PH Insulin Using Either Implantable Intraperitoneal Pump or Subcutaneous External Pump Infusion in Type 1 Diabetic Patients
Open the PDF for Comparison of Antigenicity of Hoechst 21PH Insulin Using Either Implantable Intraperitoneal Pump or Subcutaneous External Pump Infusion in Type 1 Diabetic Patients in another window
Journal Articles

Improvement of HbA1c and Blood Glucose Stability in IDDM Patients Treated With Lispro Insulin Analog in External Pumps

Vincent Melki, MD, Eric Renard, MD, Véronique Lassmann-Vague, MD, Sophie Boivin, MD, Bruno Guerci, MD, Héléne Hanaire-Broutin, MD, Jacques Bringer, MD, Pauline Belicar, MD, Nathalie Jeandidier, MD, Laurent Meyer, MD, Patrick Blin, PHD, Béatrice Augendre-Ferrante, MD, Jean-Pierre Tauber, MD
Journal: Diabetes Care
Diabetes Care 1998;21(6):977–982
https://doi.org/10.2337/diacare.21.6.977
Published: 01 June 1998
View article titled, Improvement of HbA<sub>1c</sub> and Blood Glucose Stability in IDDM Patients Treated With Lispro Insulin Analog in External Pumps
Open the PDF for Improvement of HbA<sub>1c</sub> and Blood Glucose Stability in IDDM Patients Treated With Lispro Insulin Analog in External Pumps in another window
Journal Articles

Decreased Severe Hypoglycemia Frequency During Intraperitoneal Insulin Infusion Using Programmable Implantame Pumps

Nathalie Jeandidier, MD, Jean-Louis Selam, MD, Eric Renard, MD, Bruno Guerci, MD, Veronique Lassman-Vague, MD, Laure Rocher, MD, Hélène Hanaire-Broutin, MD, The Evadiac Study Group
Journal: Diabetes Care
Diabetes Care 1996;19(7):780
https://doi.org/10.2337/diacare.19.7.780
Published: 01 July 1996
View article titled, Decreased Severe Hypoglycemia Frequency During Intraperitoneal Insulin Infusion Using Programmable Implantame Pumps
Open the PDF for Decreased Severe Hypoglycemia Frequency During Intraperitoneal Insulin Infusion Using Programmable Implantame Pumps in another window
Journal Articles

Feasibility of Intraperitoneal Insulin Therapy With Programmable Implantable Pumps in IDDM: A multicenter study

Hélène Hanaire-Broutin, MD, Christiane Broussolle, MD, Nathalie Jeandidier, MD, Eric Renard, MD, Bruno Guerci, MD, Marie-Joelle Haardt, MD, Veronique Lassmann-Vague, MD, The EVADIAC study group
Journal: Diabetes Care
Diabetes Care 1995;18(3):388–392
https://doi.org/10.2337/diacare.18.3.388
Published: 01 March 1995
View article titled, Feasibility of Intraperitoneal Insulin Therapy With Programmable Implantable Pumps in IDDM: A multicenter study
Open the PDF for Feasibility of Intraperitoneal Insulin Therapy With Programmable Implantable Pumps in IDDM: A multicenter study in another window